AACR Annual Meeting 2023: News and Highlights
The AACR Annual Meeting is where the cancer research community gathers to explore and expand the frontiers of discovery science and deliver the next breakthroughs in cancer care. The 2023 edition of the most important cancer meeting in the world featured the following highlights:
- More than 21,700 registrants (including more than 20,000 in-person registrants) from 87 countries and territories participated in the meeting
- A total of 243 clinical trials were presented; this largest-ever clinical program featured 16 Phase III trials, including several practice-changing studies
- A diverse program featuring 630 invited speakers from 25 countries (49% women, 35% minority, 9% early-career), including 14 NextGen Stars selected for podium presentations through a competitive application process
- More than 220 reporters covered the meeting, generating more than 6,500 media clips in high-profile outlets such as NBC News, CBS Evening News, CNN, The Wall Street Journal, USA Today, Reuters, and Politico
- Nearly 8,000 people joined the Annual Meeting conversation on Twitter, sharing more than 30,000 tweets using the #AACR23 hashtag and generating a record number of 388 million impressions
- Nearly 300 scientific sessions were live-streamed (including plenaries, major symposia, advances sessions, education sessions, methods workshops, and proffered paper sessions); sessions remain available to registrants for on-demand viewing through Wednesday, July 19
A Wrap-Up Plenary Session summarized all of the cutting-edge basic, translational, clinical, and population science presented at the meeting.
Four Clinical Trials Plenary Sessions showcased promising new approaches for a wide range of cancers.
The sessions covered critical topics, including targeting Kras, immune ecosystems, early detection and interception, and new concepts in drug discovery and engineering.
The AACR presented 19 awards, lectureships, and prizes during the Annual Meeting.
Special sessions offered first disclosures of the structure and mechanism of 12 novel cancer agents that are moving into phase I clinical trials.
The AACR NextGen Stars program gave 14 early-career scientists the opportunity to deliver a podium presentation in a major session at the Annual Meeting.
A total of 37 papers were published in AACR journals concurrently with their Annual Meeting presentation.
The official digital news source of the AACR Annual Meeting 2023.
Cancer Research Catalyst covered the cancer science, medicine, and policy highlights from the Annual Meeting.
A total of 14 studies were highlighted in the Annual Meeting press program, 10 of which were featured in a press conferences.
Cancer Today, the AACR’s award-winning magazine and website, showcased several Annual Meeting presentations of interest to cancer patients, survivors, and caregivers.